Tentative approval from the FDA lets generic drug makers prepare for market entry while waiting for patents to expire. Learn how patent litigation, strict timelines, and paperwork errors can delay or derail generic drug launches.
Feb 2 2026
Generic immunosuppressive combinations now make lifelong transplant care affordable without sacrificing effectiveness. Learn how tacrolimus, MMF, and sirolimus generics work, their cost savings, risks, and what patients need to know to stay safe.
Feb 1 2026
Opioid-induced hyperalgesia (OIH) causes increased pain sensitivity despite opioid use. Learn how to recognize its signs-like spreading pain and allodynia-and how to treat it with dose reduction, ketamine, or methadone instead of more opioids.
Jan 27 2026
Targeted therapy uses tumor genetics to match cancer patients with precise drugs that block specific mutations. It offers better outcomes and fewer side effects than chemotherapy - but only works if the right genetic test is done.
Jan 26 2026
Authorized generics are the exact same drugs as brand-name medications, made by the original manufacturer under a different label. Discover who really produces them and why they're often cheaper - and more consistent - than regular generics.
Jan 18 2026
Menu